AstraZeneca stock pre-market at EUR 145.13: plus 0.02 percent
Published on 09/30/2026 at 08:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AstraZeneca stock was at EUR 145.13 pre-market at 8:40 a.m. CEST on September 30, 2026, according to Lang & Schwarz. The price was up plus 0.02 percent versus the Lang & Schwarz prior close of EUR 145.10.
Pre-market quote
Lang & Schwarz showed a bid of EUR 144.90 and an ask of EUR 145.35. The quote is for AstraZeneca PLC, whose primary listing is on the London Stock Exchange under ticker AZN.
Reported oncology developments
Investing.com reported on September 29, 2026, that AstraZeneca had unveiled an equity investment in Summit Therapeutics and entered a clinical collaboration involving ivonescimab. The report also said AstraZeneca submitted a U.S. Food and Drug Administration application for a savolitinib and osimertinib combination in a specific lung-cancer setting.
Previous close
The Lang & Schwarz prior close was EUR 145.10. The pre-market quote was recorded before the Xetra session opened at 9:00 a.m. CEST.
